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Abstract
Hemoperfusion (HP) was helpful to prevent the develop-
ment and progression of acute respiratory distress syndrome 
(ARDS), acute kidney injury (AKI), liver failure, and septic 
shock by removing cytokines and other inflammatory me-
diators and ultimately preventing progression toward mul-
tiple organ failure. A 54-year-old man diagnosed with COV-
ID-19 was hospitalized in the intensive care unit. The pa-
tient’s O2 saturation was 80% using an oxygen mask, which 
was gradually declining. After 4 sessions of HP/continuous 
renal replacement therapies (CRRT), O2 saturation reached 
to 95%, and the patient was transferred to the general ward. 
Performing HP/CRRT at the early stages of ARDS can obviate 
the need for intubating patients with COVID-19. Punctual 
and early use of HP and CRRT in the treatment of ARDS in 
patients with COVID-19 prevented the progression of ARDS 
and patient intubation, reduced respiratory distress and the 
patient’s dependence on oxygen, prevented other compli-
cations such as AKI and septic shock in the patient, and re-
duced mortality and hospital length of stay.
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Introduction
As with previous viral outbreaks, a percentage of pa-
tients with COVID-19 require intensive care and com-
plex management [1, 2]. Current strategies for coronavi-
rus disease 2019 (COVID-19) include extracorporeal 
membrane oxygenation (ECMO) in the most severe cases 
of acute respiratory distress syndrome (ARDS) [3], as well 
as high-flow nasal oxygen (HFNO) and mechanical ven-
tilation for intubated patients [4]. Although these mea-
sures are effective in most cases, several COVID-19 pa-
tients may present a fatal outcome. Reports from around 
